Sharonmoyee Goswami is a partner in Cravath’s Litigation Department. She focuses her practice on intellectual property, antitrust and litigation involving complex scientific issues.
Ms. Goswami represents Abiomed, a global medical device company that develops groundbreaking cardiovascular products, in two patent infringement matters in Massachusetts federal court relating to patents for guidance systems used in intravascular blood pumps. She also recently represented Alarm.com in a U.S. International Trade Commission (“ITC”) investigation initiated by EcoFactor, Inc. seeking an exclusion order to prevent certain products, among them Alarm.com’s smart thermostats, from entering the United States. The matter was tried in November 2020 in one of the first all-virtual ITC patent infringement trials.
Ms. Goswami also represented Amgen in one of the first actions to proceed under the Biologics Price Competition and Innovation Act (BPCIA), which concerned its introduction of a biosimilar to the world’s largest selling drug, Humira®. In September 2017, Amgen reached a global settlement with AbbVie, enabling Amgen to market the first approved biosimilar to Humira® in the United States and Europe.
Ms. Goswami received a B.S.E. in Chemical Engineering from Princeton University in 2009 and obtained certificates (minors) in Engineering Biology and Materials Science. At Princeton, she was awarded the inaugural leadership prize in Materials Science and Engineering. She received a J.D. magna cum laude from New York University School of Law in 2012, where she was a Florence Allen Scholar, a Senior Editor of the Journal of Intellectual Property & Entertainment Law and was elected to the Order of the Coif. At NYU, she was awarded the Walter J. Derenberg Prize in Copyright Law.
Ms. Goswami joined Cravath in 2012. She served as a law clerk to Hon. Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit in 2013. She rejoined Cravath in 2014 and was elected a partner in 2019.
Updated July 2021